Transesophageal echocardiography in patients with cryptogenic cerebral ischemia

BackgroundIn about one third of all patients with cerebral ischemia, no definite cause can be identified (cryptogenic stroke). In many patients with initially suspected cryptogenic stroke, however, a cardiogenic etiology can eventually be determined. Hence, the aim of this study was to describe the prevalence of abnormal echocardiographic findings in a large number of these patients.MethodPatients with cryptogenic cerebral ischemia (ischemic stroke, IS, and transient ischemic attack, TIA) were included. The initial work-up included a neurological examination, EEG, cCT, cMRT, 12-lead ECG, Holter-ECG, Doppler ultrasound of the extracranial arteries, and transthoracic echocardiography. A multiplane transeophageal echocardiography (TEE, including i.v. contrast medium application [Echovist], Valsalva maneuver) was performed in all patientsResults702 consecutive patients (380 male, 383 IS, 319 TIA, age 18–90 years) were included. In 52.6% of all patients, TEE examination revealed relevant findings. Overall, the most common findings in all patients were: patent foramen ovale (21.7%), previously undiagnosed valvular disease (15.8%), aortic plaques, aortic valve sclerosis, atrial septal aneurysms, regional myocardial dyskinesia, dilated left atrium and atrial septal defects. Older patients (> 55 years, n = 291) and patients with IS had more relevant echocardiographic findings than younger patients or patients with TIA, respectively (p = 0.002, p = 0.003). The prevalence rates of PFO or ASD were higher in younger patients (PFO: 26.8% vs. 18.0%, p = 0.005, ASD: 9.6% vs. 4.9%, p = 0.014).ConclusionA TEE examination in cryptogenic stroke reveals contributing cardiogenic factors in about half of all patients. Younger patients had a higher prevalence of PFO, whereas older patients had more frequently atherosclerotic findings. Therefore, TEE examinations seem indicated in all patients with cryptogenic stroke – irrespective of age – because of specific therapeutic consequences.

[1]  I. Kronzon,et al.  Valve strands are strongly associated with systemic embolization: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.

[2]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[3]  C. Duyckaerts,et al.  The prevalence of ulcerated plaques in the aortic arch in patients with stroke. , 1992, The New England journal of medicine.

[4]  S. Schuele,et al.  Single-vessel versus multivessel territory acute ischemic stroke: value of transesophageal echocardiography in the differentiation of embolic stroke. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  F. Silver,et al.  Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[6]  V. Kudithipudi,et al.  Protocol for Optimal Detection and Exclusion of a Patent Foramen Ovale Using Transthoracic Echocardiography with Agitated Saline Microbubbles , 2006, Echocardiography.

[7]  C. Mullany,et al.  Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. , 1999, Circulation.

[8]  J. Bogousslavsky,et al.  Stroke recurrence in patients with patent foramen ovale , 1996, Neurology.

[9]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials. , 2000, The New England journal of medicine.

[10]  J. Seward,et al.  Clinical and Echocardiographic Characteristics of Patients With Left Atrial Thrombus and Sinus Rhythm: Experience in 20 643 Consecutive Transesophageal Echocardiographic Examinations , 2002, Circulation.

[11]  P. Amarenco.  Cryptogenic Stroke, Aortic Arch Atheroma, Patent Foramen Ovale, and the Risk of Stroke , 2005, Cerebrovascular Diseases.

[12]  N. Bresolin,et al.  Genetic polymorphisms for the study of multifactorial stroke , 2008, Human mutation.

[13]  H. Reichmann,et al.  Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. , 2004, European heart journal.

[14]  R. Sacco,et al.  Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.

[15]  R. Sacco,et al.  Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen Ovale , 2004, Stroke.

[16]  V. Larrue,et al.  Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack , 2008, Clinical Neurology and Neurosurgery.

[17]  Jeroen J. Bax,et al.  Transesophageal Echocardiography Is Superior to Transthoracic Echocardiography in Management of Patients of Any Age With Transient Ischemic Attack or Stroke , 2006, Stroke.

[18]  Djordje Pavlovic,et al.  Accidente isquémico transitorio secundario a excrecencia de Lambl: descripción de un caso y revisión de la literatura , 2006 .

[19]  S. Windecker,et al.  Is closure recommended for patent foramen ovale and cryptogenic stroke , 2008 .

[20]  W. Edwards,et al.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. , 1984, Mayo Clinic proceedings.

[21]  B Meier,et al.  Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. , 2000, Circulation.

[22]  P. Lechat,et al.  Prevalence of patent foramen ovale in patients with stroke. , 1988, The New England journal of medicine.

[23]  Irene Katzan,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[24]  I. Bone,et al.  Interatrial septal abnormalities and stroke , 2000, Neurology.

[25]  Dusko Pavlovic,et al.  [Transient ischemic attack due to Lambl's excrescence. Report of a case and review of the literature]. , 2006, Anales de medicina interna.

[26]  S. Windecker,et al.  Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close?: Closure: What Else! , 2008, Circulation.

[27]  M. Olschewski,et al.  Patent foramen ovale and cryptogenic stroke in older patients. , 2007, The New England journal of medicine.

[28]  J. Coste,et al.  Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[29]  R. Sacco,et al.  Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. , 2007, Journal of the American College of Cardiology.

[30]  L. Teodori,et al.  Report of a Case and Review of the Literature , 1981 .

[31]  A. Slivka,et al.  Mitral valve strands in patients with focal cerebral ischemia. , 1996, Stroke.

[32]  E. Radue,et al.  Diffusion-Weighted Imaging in Stroke Attributable to Patent Foramen Ovale: Significance of Concomitant Atrial Septum Aneurysm , 2006, Stroke.

[33]  F. Silver,et al.  Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[34]  J. Coste,et al.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.